Search results
Results from the WOW.Com Content Network
Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause. [ 1 ] [ 2 ] Effects of menopause can include symptoms such as hot flashes , accelerated skin aging, vaginal dryness , decreased muscle mass , and ...
Hormone replacement therapy, or HRT (also now referred to as menopausal hormone therapy, or MHT), is an FDA-approved effective treatment designed to alleviate many menopausal symptoms.
The Heidelberg Retinal Tomography is a diagnostic procedure used in ophthalmology.The Heidelberg Retina Tomograph (HRT) is an ophthalmological confocal point scanning laser ophthalmoscope [1] for examining the cornea and certain areas of the retina using different diagnostic modules (HRT retina, HRT cornea, HRT glaucoma).
Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, for early puberty, or as part of transgender hormone therapy.
HRT most commonly refers to: Hormone replacement therapy , a treatment used to reduce symptoms associated with menopause Transgender hormone therapy , also known as hormone replacement therapy
Hormone replacement therapy for women going through menopause has been found to be associated with dry eyes, [13] which in turn is associated with blepharospasm. Blepharospasm can be caused by concussions in some rare cases, when a blow to the back of the head damages the basal ganglia.
Bioidentical hormones were first used for menopausal symptom relief in the 1930s, [2] after Canadian researcher James Collip developed a method to extract an orally active estrogen from the urine of pregnant women and marketed it as the active agent in a product called Emmenin. [3]
A subsequent study of 495 women treated with DMPA over the course of 1 year found that the mean depression score slightly decreased in the whole group of continuing users from 7.4 to 6.7 (by 9.5%) and decreased in the quintile of that group with the highest depression scores at baseline from 15.4 to 9.5 (by 38%). [82]